Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Material Requirements to Support Gene Therapy Development Clare Blue, Director of Analytical Development at Biogen and James Wilkinson, VP of Sales and Customer Success at Refeyn Manufacturing processes for gene therapy products are generally low yielding compared to production processes for other biologics. The material requir... 21 hours ago | 73 mins The Use of Stability Modelling to Support Accelerated Vaccine Development... Didier Clenet, Jos Weusten, Marilena Paludi and Cristiana Campa The Use of Stability Modelling to Support Accelerated Vaccine Development & Supply Stability assessment is particularly relevant for vaccines, due t... 4 days ago | 95 mins Vaccine Development & its Manufacturing using Integrated... Dr. S.K. Jana at Serum Institute of India Pvt. Ltd, Vikas Revankar at Merck and Piergiuseppe Nestola at Sartorius Full Title: Vaccine Development & its Manufacturing using Integrated High Throughput Technology The billions of doses of vaccines manufactured world... 8 months ago | 151 mins Digitally Transforming Pharmaceutical Process Development and Manufacturing Moiz Diwan, Ph.D. Process Research and Development, AbbVie Inc., North Chicago, IL Digitally Transforming Pharmaceutical Process Development and Manufacturing: Enabling Technologies for a Sustainable Future The focus on accelerated ... October 4, 2022 2:00pm Overcoming Antibody-Drug Conjugate (ADC) Process Development... Dr. Jimmy Li, CEO of WuXi XDC (a WuXi Biologics subsidiary) Full Title: Overcoming Antibody-Drug Conjugate (ADC) Process Development & Manufacturing Challenges Dr. Jimmy Li, CEO of WuXi XDC (a WuXi Biologics s... 3 months ago | 56 mins Target Enriched RNA-seq for SARS-CoV-2 Surveillance and Genome Analysis Sarah Trusiak, PhD, Sr. Application Scientist, Roche Sequencing and Life Science New SARS-CoV-2 strains are continuing to emerge, potentially impacting the effectiveness of existing vaccines. Thus, the ability to determine the geno... 2 weeks ago | 31 mins Conducting successful commercial research in a primary care setting Simon Royal. NIHR; Rebecca Clarke, Layton Medical Centre; Jonathan Abraham, Healum; Sheena Gomez, GlaxoSmithKline The primary care setting offers huge potential for commercial research. This was, and still is being, demonstrated through the UK’s COVID-19 vaccine r... 2 months ago | 61 mins Data as an asset – what does this mean to you? Christos Varsakelis, at The Janssen Pharmaceutical Companies of Johnson & Johnson Social media frequently depict data as the new oil. Whilst Industry 4.0 is data centric, in the sense that it promotes a data driven “piloting of the ... 1 month ago | 78 mins Path to Smart Manufacturing and Intelligent Development within Industry 4.0 Dan Hill at Biogen, Chris McCready at Sartorius Stedim Biotech and Martin Gadsby at Optimal Industrial Technologies Ltd Path to Smart Manufacturing and Intelligent Development within Industry 4.0 - Building an Integrated Sensing Strategy Over the years there have been ... September 20, 2022 2:00pm In-line monitoring of surfactant clearance... Marina Kirkitadze, Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur Full Title: In-line monitoring of surfactant clearance in viral vaccine downstream processing The focus of this study is to examine the suitability o... 3 months ago | 43 mins Load more
